Driehaus Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Driehaus Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-314,100	Closed	-$4.37M	–	438
2023 Q4	$4.37M	Sell	314,100 -439,420	-58%	-$5.87M	0.05%	272
2023 Q3	$10.1M	Buy	753,520 +197,175	+35%	+$2.67M	0.13%	206
2023 Q2	$7.02M	Buy	+556,345	New	+$6.49M	0.09%	255
2022 Q4	–	Sell	-230,525	Closed	-$2.41M	–	399
2022 Q3	$2.41M	Buy	+230,525	New	+$2.46M	0.04%	300
2015 Q4	–	Sell	-454,030	Closed	-$5.8M	–	615
2015 Q3	$5.8M	Buy	454,030 +69,000	+18%	+$857K	0.21%	116
2015 Q2	$4.26M	Buy	385,030 +125,255	+48%	+$1.38M	0.15%	171
2015 Q1	$2.97M	Buy	+259,775	New	+$2.76M	0.1%	251
2014 Q4	–	Sell	-197,515	Closed	-$2.08M	–	567
2014 Q3	$2.08M	Buy	+197,515	New	+$1.86M	0.08%	313

Other funds holding RDY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Driehaus Capital Management's RDY Position: Q1 2024 in Review

Driehaus Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 314,100 shares — an estimated $4.37M sold.

Driehaus Capital Management first reported a position in RDY in Q3 2014 and held it in 8 quarters. The position peaked at $10.1M in Q3 2023. 231 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

Driehaus Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
Driehaus Capital Management sold 314,100 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $4.37M.
Driehaus Capital Management first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 8 quarters.
Driehaus Capital Management's Dr. Reddy's Laboratories position peaked at $10.1M in Q3 2023.
231 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on Driehaus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.